Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Anticholinergic drugs or botulinum toxin for urge incontinence?

[No authors listed]

BMJ. 2012 Oct 10;345:e6732. doi: 10.1136/bmj.e6732. No abstract available.

PMID:
23054049
2.

Anticholinergic versus botulinum toxin A comparison trial for the treatment of bothersome urge urinary incontinence: ABC trial.

Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MF, Menefee SA, Schaffer J, Wei J, Chai T, Janz N, Spino C, Meikle S; Pelvic Floor Disorders Network.

Contemp Clin Trials. 2012 Jan;33(1):184-96. doi: 10.1016/j.cct.2011.09.019. Epub 2011 Oct 8.

3.

[Anticholinergic agents for overactive bladder syndrome: current head-to-head comparison].

Goepel M, Schultz-Lampel D.

Urologe A. 2011 Jul;50(7):802-5. doi: 10.1007/s00120-011-2602-y. Review. German.

PMID:
21681456
4.

Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.

Wu JM, Siddiqui NY, Amundsen CL, Myers ER, Havrilesky LJ, Visco AG.

J Urol. 2009 May;181(5):2181-6. doi: 10.1016/j.juro.2009.01.037. Epub 2009 Mar 17.

PMID:
19296983
5.

Commentary on: Anticholinergic therapy vs onabotulinumtoxinA for urgency urinary incontinence.

Kobashi KC, Patel B.

Urology. 2013 Jul;82(1):14-5. doi: 10.1016/j.urology.2012.11.019. Epub 2013 Apr 30. No abstract available.

PMID:
23642706
6.

[In overactive bladder, above all urgency is stressful. The patients know the site of each toilet].

[No authors listed]

MMW Fortschr Med. 2004 May 27;146(22):51. German. No abstract available.

PMID:
15373116
7.

Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.

Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MF, Menefee SA, Schaffer J, Lowder J, Khandwala S, Sirls L, Spino C, Nolen TL, Wallace D, Meikle SF; Pelvic Floor Disorders Network.

N Engl J Med. 2012 Nov 8;367(19):1803-13. doi: 10.1056/NEJMoa1208872. Epub 2012 Oct 4.

8.

[Treatment of overactive urinary bladder with imperative urinary incontinence in women].

Neĭmark AI, Riapolova MV, Mel'nik MA.

Urologiia. 2010 Mar-Apr;(2):36-8. Russian.

PMID:
20967993
9.

Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses.

Grise P, Ruffion A, Denys P, Egon G, Chartier Kastler E.

Eur Urol. 2010 Nov;58(5):759-66. doi: 10.1016/j.eururo.2010.06.035. Epub 2010 Jul 3.

PMID:
20674149
10.
11.

[Overactive bladder. When it's pressing, immediate help is indicated].

Widhalm S.

MMW Fortschr Med. 2008 May 15;150(20):44-5. German. No abstract available.

PMID:
18605642
12.

Low persistence of anticholinergic drug use in Sweden.

Linnér L, Schiöler H, Samuelsson E, Milsom I, Nilsson F.

Eur J Clin Pharmacol. 2011 May;67(5):535-6. doi: 10.1007/s00228-010-0917-z. No abstract available.

PMID:
21061118
13.

[Botulinum toxin in otorhinolaryngology].

Rohrbach S, Laskawi R.

HNO. 2004 Jul;52(7):635-41. Review. German.

PMID:
15156289
14.

Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder.

Kantartzis K, Shepherd J.

Curr Opin Obstet Gynecol. 2012 Oct;24(5):331-6. doi: 10.1097/GCO.0b013e3283573ff9. Review.

PMID:
22922403
15.

Solifenacin significantly improves all symptoms of overactive bladder syndrome.

Chapple CR, Cardozo L, Steers WD, Govier FE.

Int J Clin Pract. 2006 Aug;60(8):959-66. Review. Erratum in: Int J Clin Pract. 2006 Nov;60(11):1517-8.

16.

Botox® in urology--will it become standard of care for urge urinary incontinence?

Smith CP.

J Urol. 2010 Dec;184(6):2235-6. doi: 10.1016/j.juro.2010.09.050. Epub 2010 Oct 16. No abstract available.

PMID:
20952015
17.

[Efficacy and safety of imidafenacin in female patients with urge and mixed urinary incontinence].

Shimada M, Inoue K, Okumura T, Aoki S, Ogawa Y, Matsubara E, Maeda T, Ogawa Y, Sasaki H.

Hinyokika Kiyo. 2011 Jan;57(1):1-6. Japanese.

18.

[Urinary urgency].

[No authors listed]

MMW Fortschr Med. 2008 Jul 31;150(28-31):58-9. German. No abstract available.

PMID:
19009709
19.

[Overactive bladder].

Golsong J.

MMW Fortschr Med. 2013 Apr 4;155(6):44. German. No abstract available.

PMID:
23700696
20.

Botulinum toxin: new option for refractory lower urinary tract symptoms in women.

Rickey LM, Kenton K.

Clin Obstet Gynecol. 2008 Mar;51(1):176-86. doi: 10.1097/GRF.0b013e3181621fd2. Review.

PMID:
18303512

Supplemental Content

Support Center